BRUSSELS, March 19, 2026 /PRNewswire/ — Radisson Hotel Group is pleased to announce the signing of Mana Island Resort & Spa Fiji, a member of Radisson Individuals, marking a significant milestone in the Group’s South Pacific expansion and reinforcing its growing presence in Fiji’s resort market.

Set on the idyllic shores of Mana Island in Fiji’s celebrated Mamanuca archipelago, the resort enjoys a prime island setting renowned for turquoise waters, white-sand beaches, vibrant coral reefs, and year-round sunshine. Mana Island is approximately 90 minutes by boat from Port Denarau Marina and around 20 minutes by seaplane from Nadi International Airport, offering convenient access while retaining a true sense of escape.

Danilo Curcuruto, Director, Development, Australasia, Radisson Hotel Group, says: “Fiji remains one of the South Pacific’s most desirable resort destinations, and Mana Island is one of its most iconic island locations. We are delighted to welcome Mana Island Resort & Spa Fiji into our Radisson Individuals portfolio. This signing reflects our continued focus on expanding our resort footprint in high-potential leisure destinations while offering owners flexible brand solutions that preserve a property’s unique identity and unlock the power of Radisson’s global reach.”

The 160-key resort will undergo a comprehensive refurbishment and repositioning to create an upscale island resort experience that seamlessly blends contemporary design, authentic Fijian character, and immersive nature-led experiences. The project is expected to open under the Radisson Individuals brand following completion of the remodeling in late 2027.

The resort will feature a diverse mix of guest rooms, suites, and beachfront villas, complemented by multiple dining venues, bars, swimming pools, spa and wellness facilities, a fitness centre, a kids’ club, and event spaces. The offering is designed to appeal to leisure travelers, couples, families, and small-scale groups seeking a relaxed yet elevated island lifestyle.

Radisson Individuals is Radisson Hotel Group’s collection brand for distinctive hotels that celebrate their individuality while benefiting from Radisson’s global distribution, loyalty platform, and operational expertise.

“We are excited to partner with Radisson Hotel Group and align Mana Island Resort & Spa Fiji with the Radisson Individuals brand,” adds Hiro Osuka, owner of Mana Island Resort & Spa Fiji, “Radisson’s global reach, strong distribution platform, and experience in lifestyle and resort hospitality will support our vision to elevate Mana Island into a leading upscale island resort that delivers a compelling experience for guests from around the world.”

This signing represents Radisson Hotel Group’s third resort in Fiji, joining Radisson Blu Resort, Fiji Denarau Island and the Radisson Blu Mirage Resort, Fiji Naisoso Island, currently under construction.

The announcement follows Radisson Hotel Group’s recent signing of a resort in Samoa, further demonstrating the Group’s ongoing commitment to strategic expansion across Australasia and the Pacific, where the Group continues to build a strong pipeline across its core brands.

ABOUT RADISSON HOTEL GROUP 

Radisson Hotel Group is a rapidly expanding international hotel group, operating in EMEA and APAC with more than 1,600 hotels in operation and under development in +100 countries. The Group’s overarching brand promise is Every Moment Matters with a signature Yes I Can! service ethos. 

The Radisson brand portfolio includes Radisson Collection, art’otel, Radisson Blu, Radisson, Radisson RED, Radisson Individuals, Park Plaza, Park Inn by Radisson, Country Inn & Suites by Radisson, and Prize by Radisson — brought together under one commercial umbrella brand, Radisson Hotels.  

Radisson Rewards is Radisson Hotel Group’s loyalty program, which delivers an elevated experience that makes Every Moment Matter, counting more than 27 million members. As the most streamlined program in the sector, members enjoy exceptional advantages and can access their benefits from day one across a wide range of hotels in Europe, Middle East, Africa, and Asia Pacific.  

Radisson Meetings provides tailored solutions for any event or meeting, including hybrid solutions, placing guests and their needs at the heart of its offer. Radisson Meetings is built around three strong service commitments: Personal, Professional, and Memorable, while delivering on the brilliant basics and being uniquely Carbon Compensated.  

At Radisson Hotel Group, we care for people, communities, and planet and aim to be Net Zero by 2050 based on the approved Science Based Targets. With unique solutions such as carbon-compensated Radisson Meetings, we make sustainable hotel stays easy. To facilitate sustainable travel choices, all our hotels are becoming verified on Hotel Sustainability Basics. 

The health and safety of guests and team members remain a top priority for Radisson Hotel Group. All properties across the Group’s portfolio are subject to health and safety requirements, ensuring we always care for our guests and team members. 

For more information, visit our corporate website. Or connect with Radisson Hotels on:  

LinkedIn | TikTok | Instagram | Facebook | YouTube | WhatsApp | X 

ABOUT RADISSON INDIVIDUALS

Radisson Individuals is an affiliation brand comprised of independent hotels, each boasting its own unique identity and united by Radisson Hotel Group’s service philosophy and attention to detail. The brand consists of: Radisson Individuals, Radisson Individuals Premier, Radisson Individuals Boutique, and Radisson Individuals Retreats.

Radisson Individuals is created to offer a solution for independent and unbranded hotels to become part of the Group’s family. Radisson Individuals brings together hotels that have unique characteristics and personalities, offering guests an opportunity to discover new locations whilst safe in the knowledge that they will always receive the high standards of quality and service they rely on from Radisson Hotel Group. Radisson Individuals properties are located in key business and leisure destinations.

Radisson Individuals Premier offers a curated selection of upper-upscale hotels in key business and leisure destinations, with state-of-the-art facilities for both business and leisure. Radisson Individuals Premier hotels consist of elegantly appointed rooms, unparalleled attention to detail, offering a seamless blend of style and service.

Radisson Individuals Boutique provides a portfolio of intimate boutique hotels, blending exclusive, stylish settings with impeccable service. These hotels are situated in leisure and business destinations around the world, for those who want to experience local charm. Radisson Individuals Boutique properties are thoughtfully curated to provide a bespoke and uniquely local stay.

Radisson Individuals Retreats provides unique opportunities to become immersed in out-of-the-ordinary experiences, and recharge and reconnect in natural surroundings. Situated in scenic leisure destinations, these lifestyle hideaways connect guests with the authentic spirit of the location, focusing on nature while ensuring the highest standards of quality and service.

Guests and professional business partners can enhance their experience with Radisson Individuals by participating in Radisson Rewards, an international loyalty program offering exceptional benefits and rewards.

Radisson Individuals is a part of the Radisson family of brands, which also includes Radisson Collection, art’otel, Radisson Blu, Radisson, Radisson RED, Park Plaza, Park Inn by Radisson, Country Inn & Suites by Radisson, and Prize by Radisson, brought together under one commercial umbrella brand – Radisson Hotels.

For reservations and more information, visit our website. Or connect with Radisson Hotels on:

LinkedIn | TikTok | Instagram | Facebook | YouTube | WhatsApp |  

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 19, 2026 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the appointment of Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation. Dr. Xie will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and Chief Executive Officer of Harbour BioMed.

In this role, Dr. Xie will lead Harbour BioMed’s global external innovation strategy in immunology, managing ongoing strategic collaborations with key partners, as well as identifying and pursuing new partnership opportunities. Additionally, she will oversee all activities at the company’s Harbour BioMed-AstraZeneca Innovation Lab in Beijing.

Dr. Xie brings more than 25 years of experience in the biopharmaceutical industry. Prior to joining Harbour BioMed, she served as Executive Director and Head of Discovery Immunology at Bristol Myers Squibb, where she led research efforts in autoimmune diseases and contributed to the discovery, evaluation, and clinical translation of novel therapeutic approaches. Prior to that, she also held scientific leadership roles at Merck, building extensive experience in early-stage research and development.

Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: “We are very pleased to welcome Dr. Jenny Xie to our executive team. Her extensive experience in drug discovery and development in immunology will be invaluable as we work to strengthen our R&D capabilities and drive innovation across our pipeline. I am confident her leadership will significantly advance our immunology research and global collaboration efforts.”

Dr. Jenny Xie, Chief Scientific Officer, Immunology and Head of Global External Innovation of Harbour BioMed, added: “I am truly excited to join an incredible company like Harbour BioMed and look forward to working with everyone toward our shared goal of transforming patients’ lives through innovation, speed, and global collaboration.”

Dr. Xie received her Ph.D. in Immunology from Boston University School of Medicine and her bachelor’s degree in Biology from Fudan University.

About Harbour BioMed

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas. The Company is building a robust portfolio and differentiated pipeline through internal R&D capability, strategic global collaborations in co-discovery and co-development, and selective acquisitions.

Our proprietary antibody technology platform, Harbour Mice^®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the heavy chain-only (HCAb) format. Building upon HCAb antibodies, the HCAb-based immune cell engagers (HBICE^®) bispecific antibody technology enables tumor-killing effects that traditional combination therapies cannot achieve. The HCAb-based Antibody Plus technology (HCAb PLUS^TM) provides comprehensive modality solutions for the development of innovative multi-specific medicines in different disease areas. Additionally, building upon the Harbour Mice^® platform, Harbour BioMed launched its first fully human Generative AI HCAb Model powered by its Hu-mAtrIx^TM AI platform, accelerating the development of innovative therapies.

By integrating Harbour Mice^®, HBICE^®, HCAb PLUS^TM, a single B-cell cloning platform and AI technologies, Harbour BioMed has built a highly efficient and distinctive antibody discovery engine for developing next-generation therapeutic antibodies. For more information, please visit www.harbourbiomed.com.

TAIPEI, March 19, 2026 /PRNewswire/ — HD Renewable Energy (TPEX: 6873), a leading international smart energy company, announced that its Helios 50MW grid-scale battery energy storage system (BESS) project in Hokkaido, Japan, has secured project financing of approximately JPY 5.4 billion.

The financing was arranged with the support of Nomura Capital Investment and Nomura Securities, and raised through a green project bond, marking Japan’s first green project bond backed by grid-scale battery storage assets. The transaction highlights growing interest from global capital markets in energy storage infrastructure and market-driven power trading models.

The financing adopts a project finance trust beneficiary right structure (ABL), with the HDRE Group serving as the asset manager. The Helios project operates under a merchant model, generating revenue primarily through electricity trading in Japan’s wholesale power market (JEPX) and balancing market (EPRX).

Unlike renewable projects that rely on subsidies or long-term fixed-price contracts, merchant battery storage projects have revenue streams directly linked to market prices, making them a more challenging asset class for traditional project finance. Through a structured operational and cash-flow management framework, the project successfully secured long-term financing with a maturity of up to 19 years, representing an important milestone for battery storage financing in Japan.

As renewable energy penetration continues to rise in Japan, demand for flexible dispatch and grid balancing resources is increasing. Grid-scale battery storage is emerging as a critical infrastructure component to support grid stability and enable higher renewable integration. However, project finance markets have historically favored assets with predictable cash flows, such as FIT-supported projects. Battery storage projects, whose revenues depend on electricity market conditions, have therefore seen relatively limited long-term financing. The successful issuance of the Helios green project bond demonstrates growing investor confidence in energy storage assets and market-based electricity trading models.

“The successful financing of the Helios project marks an important step in establishing a viable financial framework for battery storage assets in Japan,” said Jason Chou, General Manager of HD Renewable Energy. “It also reflects increasing market confidence in power trading-driven business models. As our storage portfolio continues to expand, we will further integrate asset operations with power trading capabilities to enhance the flexibility and value of energy asset management.”

The Helios BESS project, with a capacity of 50MW, is already participating in Japan’s electricity markets and conducting power trading operations. The project is expected to gradually participate in the balancing market and capacity market to further enhance asset performance.

The project has received BBB investment-grade credit and green bond ratings from Rating and Investment Information, Inc. (R&I) and has also obtained a Second-Party Opinion (SPO) confirming its alignment with Green Bond Principles. Going forward, HDRE will continue to strengthen cooperation with international financial institutions including the Nomura Group, while advancing integrated operations of battery storage and power assets and expanding its smart energy footprint in Japan.

Fusing Eastern Wellness Wisdom with Advanced Algorithms to Usher in a “New Era of Proactive Wellness”

NEW YORK, March 19, 2026 /PRNewswire/ — On March 16, Chinese AI tech brand Andun illuminated New York’s Times Square, marking its official introduction to the global market. By pioneering a technological path that integrates the concepts of traditional Chinese wellness with modern artificial intelligence, Andun continues to explore groundbreaking possibilities in the proactive health and lifestyle sector.

During the global brand showcase, Andun Founder Bai Weimin emphasized the company’s dedication to driving the evolution of personal well-being through technological innovation. “We hope to help global users better understand their overall wellness status through smarter algorithms and more comprehensive trend analyses,” Bai Weimin stated.

At the core of Andun’s brand ecosystem is its proprietary “Tianhui AI Pulse Analysis Algorithm”. This innovative system seamlessly combines traditional wellness principles with deep learning models to interpret holistic health signals. Rather than relying solely on traditional hardware measurements, Andun places a stronger emphasis on the role of its central algorithms to observe personal wellness trends and generate highly personalized lifestyle, fitness, and nutritional recommendations.

Expanding its proactive wellness ecosystem, Andun highlighted its flagship innovation: the AI Wellness Robot. This smart interactive companion acts as a tangible manifestation of the brand’s powerful algorithm, bringing personalized Eastern wellness insights directly into users’ daily lives. Recently, the robot garnered widespread attention and generated significant buzz at the Beijing Artificial Intelligence and Robotics Conference, drawing crowds and sparking industry conversations.

Prominent Chinese media such as People’s Daily Online and 36Kr noted that Andun’s integration of traditional wellness wisdom and modern technology showcases a promising new direction for independent innovation by Chinese tech enterprises. As the global proactive well-being market continues to evolve, technological paths based on diverse wellness frameworks are expected to collectively drive the industry forward. Through this launch, Andun aims to provide global users with expanded choices, officially pioneering and defining the next generation of smart wellness.

SINGAPORE, March 19, 2026 /PRNewswire/ — UOB has successfully priced an RMB 5.0 billion three-year bond at 1.83 per cent.

UOB was the first Singaporean issuer and only Singaporean bank in the Panda bond market. This is the Bank’s third Panda bond since its debut in 2019 and the sixth Chinese interbank bond offering by the Group, including issuances from UOB China, demonstrating the Group’s long-standing commitment to the capital markets in China. Our Panda bond offering in 2024 was the first time a bank listed a Panda bond on the Singapore Exchange (SGX). Similar to 2024, UOB will also apply for this bond to be listed on SGX subject to regulatory approval.

This offering garnered strong demand with a subscription ratio of 1.6x times from both onshore and offshore investors – 22 per cent of participation from offshore investors, with onshore investors taking 78 per cent. 

This is the joint largest issue size for a three-year tenor among foreign bank issuers, equal to that attained by UOB in 2024. The size achieved is 1bn to 3bn larger than the equivalent 3Y tranches by other foreign bank peers earlier this year.

The final coupon of 1.83 per cent represents a spread of 22 basis points over the three-year China Development Bank benchmark bond yield. The coupon and spread achieved is one of the lowest achieved by an international foreign bank (excl HK) Panda bond issuer to date.

With USD markets largely closed due to geopolitical volatility, the onshore RMB market has remained stable, with onshore issuances remaining normal and yields remaining compressed.

Ms Koh Chin Chin, Head of Group Treasury, Research and Customer Advocacy, UOB, said, “We’re pleased to complete our CNY5 billion Panda bond issuance with strong investor support. As a repeat issuer, we appreciate the depth and resilience of the onshore RMB market, which has remained stable despite a challenging geopolitical backdrop. We remain committed to deepening our long–standing engagement with China’s RMB investor community and supporting the continued growth of the Panda bond market.”

Transaction highlights

• The trade was marketed with a range of 1.70 to 2.10 per cent saw strong momentum with orderbooks reaching almost 6bn within 3 hours and marginal rate decreasing from to 2.10 per cent to 1.84 per cent by 5pm. There was a 1.1x cover ratio at the final coupon of 1.83%.
• Final orderbooks reached RMB 8.2 billion with a cover ratio at 1.6x

Distribution

Geography:

• Onshore investors in China – 78%
• Offshore investors – 22%

Investor type:

• Banks – 95%
• Securities firms – 5%

Bank of China is the Lead Underwriter and Lead Bookrunner, while Industrial and Commercial Bank of China Limited is the Lead Underwriter and Joint Bookrunner, and Agricultural Bank of China Limited, China Construction Bank Corporation, China Galaxy Securities Co., Ltd., China Securities Co., Ltd., CITIC Securities Company Limited, Deutsche Bank (China) Co., Ltd., The Export-Import Bank of China, Fubon Bank (China) Co., Ltd, Industrial Bank Co., Ltd, MUFG Bank (China), Ltd., Postal Savings Bank of China Co., Ltd., Standard Chartered Bank (China) Limited and Sumitomo Mitsui Banking Corporation (China) Limited are Joint Lead Underwriters and Joint Bookrunners.